Tag: well-as-rival
-
New data on risk vs benefit for potent CAR-T cancer drugs
A promising but risky new group of customized cancer drugs will be in focus this weekend at the annual meeting of the American Society of Hematology (ASH), where clinical trial results will help clarify their potential for doctors and investors. Experimental chimeric antigen receptor T-cells, or CAR-Ts, are made by genetically altering a patients’ own…
-
New data on risk vs benefit for potent CAR-T cancer drugs
A promising but risky new group of customized cancer drugs will be in focus this weekend at the annual meeting of the American Society of Hematology (ASH), where clinical trial results will help clarify their potential for doctors and investors. Experimental chimeric antigen receptor T-cells, or CAR-Ts, are made by genetically altering a patients’ own…
-
U.S. pushes to close lead testing gaps, echoing Reuters report
By Joshua Schneyer and M.B. Pell NEW YORK (Reuters) – U.S. states must do more to ensure that all children enrolled in the Medicaid health care program are tested for lead poisoning, a U.S. Government agency said this week, acknowledging major gaps in screening that were highlighted in a recent Reuters investigation. In a bulletin…
-
U.S. pushes to close lead testing gaps, echoing Reuters report
By Joshua Schneyer and M.B. Pell NEW YORK (Reuters) – U.S. states must do more to ensure that all children enrolled in the Medicaid health care program are tested for lead poisoning, a U.S. Government agency said this week, acknowledging major gaps in screening that were highlighted in a recent Reuters investigation. In a bulletin…
-
Wal-Mart to settle U.S. lawsuit over benefits for same-sex spouses
Wal-Mart and lawyers for Jacqueline Cote, the worker who filed the 2015 lawsuit in federal court in Boston, said in a court filing that the money may be split among more than 1,000 people who were denied spousal benefits between 2011 and 2014, when Wal-Mart changed its policy. Sally Welborn, a senior vice president at…